{
    "medicine_id": "e052e0190d0d5c8d44c43a0aac567fd521c88f23",
    "platform_id": "6299",
    "metadata": {
        "name": "Aminophylline Injection BP",
        "composition": "Each ml contains 25mg of Aminophylline Ph Eur For the full list of",
        "clinical_particulars": {
            "therapeutic_indications": "Disease of the cardiovascular system e g an adjunct in the treatment of pulmonary oedema or paroxysmal nocturnal dyspnoea caused by left ventricular heart failure reversible airways obstruction including status asthmaticus and acute bronchospasm",
            "contraindications": {
                "disease": "The use of Aminophylline is contraindicated in patients with hypersensitivity to ethylenediamine or those allergic to the theophyllines caffeine or theobromine or to any of the excipients listed in section 6 1 Aminophylline should not be administered concomitantly with other xanthine drugs When therapeutic doses of Aminophylline and or theophylline are administered simultaneously by more that one route or in more than one preparation the hazard of serious toxicity is increased The use of Aminophylline IV in children under 6 months of age is not recommended The use of Aminophylline is contraindicated in patients with acute porphyria",
                "pregnancy": "Applicable",
                "machine_ops": "Not Applicable",
                "excipients": "Ethylenediamine Ph. Eur.",
                "incompatibilities": "Aminophylline injection is not stable in solutions having a pH of substantially less than 8, however, the drug appears to be relatively stable in large volume parenteral solutions over a wide pH range (3.5-8.6) if Aminophylline concentrations do not exceed 40mg per ml. The activity of alkali-sensitive drugs will be reduced by Aminophylline, these drugs should not be added to IV fluids containing Aminophylline."
            }
        },
        "revision_date": "2022-08-16"
    }
}